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We design new primers for the
amplification of Babesia microti beta-
tubulin gene.
 We reconstruct the phylogeny of the
first isolate of B. microti from
Australia.
 The first Australian isolate of B.
microti shows homology to known
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18Sa b s t r a c t
In 2012, the first autochthonous Australian case of human babesiosis was reported, after microscopic
examinations of blood samples revealed intra-erythrocytic parasites in a hospitalized 56 year-old man
from NSW, who died in 2011 (Senanayake et al., 2012). Independent molecular analyses carried out in
Australia and the USA, identified Babesia microti at the 18S ribosomal RNA (18S rRNA), and the beta-
tubulin (b-tubulin) gene loci. Here we present the details of a novel PCR-based assay for the b-tubulin
gene that was developed, during the original study, to corroborate the results obtained from the analysis
of the 18S rDNA. The complete phylogenetic reconstruction, based on the two loci sequenced from the
Australian clinical isolate, is also shown here for the first time.
 2014 Published by Elsevier Inc.58
631. Introduction mammals after the trypanosomes (Telford III and Maguire,
64
65
66Protozoa of the genus Babesia (Piroplasmida, Apicomplexa) are
thought to be the second most common blood-borne parasites of67
68
69
702006). Over 100 species have been identified, infecting many
mammalian and some avian species (Schnittger et al., 2012; Uilen-
berg, 2006). Babesia spp. are the aetiologic agents of babesiosis, a
tick-transmitted disease causing a significant global socio-eco-
nomic burden in humans, livestock and companion animals.
Human babesiosis is a globally emerging zoonosis. Clinical fea-
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27 March 2014accompanied by haemolytic anaemia, and possibly organ failure.
With exceptions, human babesiosis is caused predominantly
by Babesia microti (in the USA) and B. divergens (in Europe), but,
prior to 2012, has never been found in Australia (Hunfeld et al.,
2008).
The first Australian case of human babesiosis was reported in
2012, after microscopic examination of blood samples from a hos-
pitalized 56-year-old man from NSW (who died in 2011), revealed
intra-erythrocytic parasites (Senanayake et al., 2012). Tradition-
ally, the extensive genetic variability, at the 18S ribosomal RNA
(18S rRNA), and beta-tubulin (b-tubulin) loci, has been exploited
to develop diagnostic molecular tests and reconstruct piroplasm
phylogeny (Cacciò et al., 2000; Schnittger et al., 2012). During
the 2012 Australian investigation, these two markers were suc-
cessfully utilised, but the details of the molecular analyses were
not included in the original report (Senanayake et al., 2012). Simi-
larly, although BLAST searches and preliminary analyses conducted
suggested a strong similarity between the Australian genotype and
other variants available in GenBank, detailed phylogenetic recon-
structions (including trees) were not presented (Senanayake
et al., 2012).
Thus, the present paper deals with the description of the molec-
ular confirmation of the first diagnosis of babesiosis in Australia,
and the development of a novel PCR-based assay at the b-tubulin
locus, used to corroborate the results obtained from the analysis











1432. Material and methods
2.1. Beta-tubulin primer design
Iterative alignments and phylogenetic reconstructions, based on
several known B. microti sequences available from GenBank (n > 50),
were carried out using Clustal W (Larkin et al., 2007), MEGA 5
(Tamura et al., 2011), and Geneious 7.0.4 (Biomatters Ltd., NZ).
Two consensus sequences were generated based on two clusters
(namely I and II) of highly similar b-tubulin genotypes, and five no-
vel PCR primer sets were designed using Primer3 (Rozen and Skalet-
sky, 2000) (Fig. 1, and Table 1 primers).Fig. 1. Binding sites of the novel b-tubulin primers. Map of the binding sites for the n
including highly similar variants of the b-tubulin gene available from GenBank, were chos
primer sets. Base numbers refer to the alignment used during primer design.
Please cite this article in press as: Paparini, A., et al. Molecular confirmation of t
primer set for the beta-tubulin gene. Exp. Parasitol. (2014), http://dx.doi.org/12.2. Molecular analyses
Genomic DNA was isolated from whole blood/EDTA (100 lL),
using the MasterPure Purification Kit (Epicentre Biotechnologies,
USA), and resuspended in 50 lL of TE buffer. Three blood samples
were collected from the patient within a week. Sequencing of the
piroplasm-specific 18S rDNA complete locus was achieved, inde-
pendently, by two laboratories in USA and Australia, using various
sets of PCR primers, as previously described (Senanayake et al.,
2012).
The novel b-tubulin primer sets were used to amplify 1 lL of
genomic DNA from the patient. A gradient PCR protocol, with six
temperature steps, and the following amplification conditions,
were used in a G-Storm thermal cycler (G-Storm, UK): 94 C –
5 min; then 40 cycles of: 94 C – 30 s, 55–62 C – 30 s, 72 C –
1 min; followed by 72 C – 7 min and 4 C – hold. PCR products
were run on a 1% agarose gel containing SYBR Safe Gel Stain (Invit-
rogen, USA), and visualised with a dark reader trans-illuminator
(Clare Chemical Research, USA). Each reaction (25 lL) included:
0.25 lM of each primer, 1.5 mM MgCl2, and 0.002 U Kapa Taq
(Kapa Biosystems, USA). PCR products corresponding to the ex-
pected length were excised from the gel, purified using a MO BIO
UltraClean DNA purification kit (MO BIO Laboratories, USA) and
sequenced using an ABI Prism Terminator Cycle Sequencing kit
(Applied Biosystems, USA), on an Applied Biosystem 3730 DNA
Analyzer. Sequences obtained were submitted to GenBank with
Acc. No. JX417370 (18S rDNA), and JX417371 (b-tubulin).
2.3. Phylogenetic reconstruction
Phylogenetic analyses by the Maximum Likelihood (ML) meth-
od (500 replicates), were performed in MEGA 5 (Tamura et al.,
2011), and by PhyML (Guindon et al., 2010) on the Phylogeny.fr
platform (Dereeper et al., 2008). Nucleotide substitution models
were chosen based on the Bayesian Information Criterion (BIC),
calculated in MEGA 5. All positions containing gaps and missing
data were eliminated.
For 18S rDNA, the evolutionary history was inferred based on
the HKY85 model (Hasegawa et al., 1985). A discrete Gamma dis-
tribution was used to model evolutionary rate differences amongovel primer sets designed. Two clusters, namely I and II (n = 15 and 6 sequences),
en to generate a consensus sequence (one for each cluster), and design the novel PCR



















gi | 5913980 B. microti Kobe524 (human) JAPAN
gi | 56550521 B. microti RcMS201 (rodent) TAIWAN
gi | 84095138 B. microti NcHZ509 (rodent) CHINA
gi | 84095139 B. microti NcTT512 (rodent) CHINA
gi | 84095140 B. microti NcWY504 (rodent) CHINA
gi | 163943657 B. microti MM-1 (macaque) 
gi | 83016537 B. microti ATCC 30222
gi | 83016535 B. microti AsHK/SP301 (rodent) JAPAN 
gi | 51702893 B. microti Gray (human) 
gi | 497258 B. microti Ruebush-Peabody (mouse)
gi | 14530220 B. microti GI (human) USA 
gi | 407316676 B. microti FB (human) AUSTRALIA
gi | 29420497 B. microti Xinjiang 1647 (rodent) CHINA 
gi | 148536465 B. microti Jena/Germany (human) GERMANY 
gi | 20804398 B. microti HK (rodent) GERMANY 
gi | 14530221 B. microti Berlin (tick) GERMANY 
gi | 83017071 B. microti EaNG/HP302 (rodent) JAPAN
gi | 83016532 B. microti Nagano (rodent) JAPAN
gi | 84095151 B. microti AaAO401 (rodent) JAPAN
gi | 84095150 B. microti AsAW/KH002 (rodent) JAPAN
gi | 84095148 B. microti Hachimaki (rodent) JAPAN 
gi | 51241749 B. microti Otsu (rodent) JAPAN 
gi | 11094303 B. microti Hobetsu (rodent) JAPAN 







Fig. 2. Phylogenetic analysis of the 18S rDNA gene. Phylogenetic analysis of the 18S rDNA gene obtained with the Maximum Likelihood (ML) method (500 replicates). The
percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) is shown next to the branches. The sequence analysed
during this study [gi | 407316676 B. microti FB (human) AUSTRALIA] is underlined and in bold.
Table 1
Oligonucleotides for the molecular detection of Babesia microti b-tubulin gene, designed during this study. The column ‘‘cluster’’ refers to the two major groups of sequences
(arbitrarily named cluster I and II, with no systematic validity), which were identified while designing the b-tubulin primers. For each oligonucleotide the melting temperature
(Tm) is indicated, while product length refers to the amplicon product, expected for each primer pair.
Cluster Primer name Primer pair ID Sequence (50?30) Tm Product length
I BMTub2|104F A TGGACCTAGAGCCTGGTACCATGG 58.97 752
BMTub2|855R TGCCTCTTCGTGGATCCGAAGCA 60.24
BMTub2|190F B TCTGGTGCAGGTAACAATTGGGC 57.53 412
BMTub2|601R TCGCCATAGGTAGGGGTGCTT 57.02
BMTub2|496F C TGCACCAACTGGTTGAGAATGCT 57.14 358
BMTub2|853R CCTCTTCGTGGATCCGAAGCACAC 59.60
II BMTub1|71F D GTGGTGGTAGATACGTACCAAGGGC 58.65 847
BMTub1|917R TTTGCTCATCAACCTCTTTGGTGCT 57.37
BMTub1|73F E GGTGGTAGATACGTACCAAGGGCCA 59.54 717
BMTub1|789R GGTACGGTGAGTGCCCTGTATTG 57.20
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27 March 2014sites (6 categories (+G, parameter = 0.15)). The analysis involved
24 nucleotide sequences, and 907 total positions in the final
dataset.
For b-tubulin, the evolutionary history was inferred based on the
Tamura 3-parameter model (Tamura 1992). A discrete Gamma dis-
tribution was used to model evolutionary rate differences among
sites (6 categories (+G, parameter = 0.45)). The analysis involved
33 nucleotide sequences, and 781 total positions in the final dataset.
Codon positions included were 1st + 2nd + 3rd + Noncoding.Please cite this article in press as: Paparini, A., et al. Molecular confirmation of t
primer set for the beta-tubulin gene. Exp. Parasitol. (2014), http://dx.doi.org/12.4. Specificity and sensitivity testing
A specificity test was carried out using 1 lL of genomic DNA, ex-
tracted from various frozen animal bloods (n = 16). Screened ani-
mal hosts included: mice (n = 2; B. microti positive by
microscopy), woylies (Bettongia penicillata ogilbyi; n = 10; Babesia
sp. positive by PCR/microscopy), a boodie (Bettongia lesueur;
n = 1; Theileria sp. positive by PCR/microscopy), and dogs (n = 3;










































Fig. 3. Phylogenetic analysis of the b-tubulin gene. Phylogenetic analysis of the b-tubulin gene obtained with the Maximum Likelihood (ML) method (500 replicates). The
percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) is shown next to the branches. The sequence obtained using
the novel primer sets reported in this study [gi | 407316677 B. microti FB (human) AUSTRALIA] is underlined and in bold.
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27 March 2014Most of the marsupial samples (7 woylies and the boodie) had
been certified as piroplasm-positive during a previous study (by
PCR/sequencing) (Paparini et al., 2012). The remaining samples
were selected for the specificity test, based on unpublished micro-
scopic screenings of blood films, which had revealed the presence
of possible piroplasm-like inclusions. Based on the performance in
the preliminary trials, and the potential informative value of
the expected amplicon (847 bp), primer set D (BMTub1|71F/
BMTub1|917R; Table 1) was selected.
A sensitivity test was carried out starting from two independent
1:10 serial dilutions of one of the patient’s genomic DNA prepara-
tions (piroplasm-positive; neat concentration: 40 ng/lL). DNA was
diluted down to 4 pg/lL (i.e., 0.0001X), and each replicate serial
dilution amplified with all 5 primer pairs. For each 25 lL PCR reac-
tion, 1 lL of DNA (neat or diluted) was used.
For both tests, thermal cycling conditions were the same as in








The ML tree based on the partial 18S rDNA fragment obtained at
Murdoch University (907 total positions in the final alignment)
showed that the Australian human isolate was, genotypically,Please cite this article in press as: Paparini, A., et al. Molecular confirmation of t
primer set for the beta-tubulin gene. Exp. Parasitol. (2014), http://dx.doi.org/1highly similar to Asian and North American variants, isolated from
rodents and humans (Fig. 2). When the full length 18S consensus
was successively assembled from contigs independently obtained
(lengths range: 154–1767 bp) (Senanayake et al., 2012), the
Australian isolate showed 100% homology to the unpublished B.
microti isolate Gray (Acc. No. AY693840), isolated from a lab host
(hamster).
All the five novel primer sets provided positive amplification
from the patient’s DNA, particularly at the lowest range of anneal-
ing temperatures (e.g., 55.1–55.6 C) (data not shown). The five
partial b-tubulin sequences obtained (318–798 bp), were assem-
bled into a consensus sequence of 798 bp. This was used to confirm
the morphological and 18S rDNA-based identifications of B. microti
from the patient’s blood (Senanayake et al., 2012).
A ML tree based on the b-tubulin gene (n = 33 sequences;
n = 781 characters in the final datasets) revealed that the Austra-
lian human isolate clustered with various North American strains
of B. microti (100% homology). Some of these had been obtained
from the tick species Ixodes scapularis (formerly known as Ixodes
dammini) (Wilson, 1998), others from humans, shrews and rodents
(Fig. 3). The phylogenetic position of this Australian piroplasm con-
firms the results obtained at the 18S locus (Senanayake et al.,
2012).
The specificity test provided negative amplification from all ani-
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27 March 2014various human-derived B. microti variants. This finding seems
corroborated by BLAST searches also strongly suggesting a higher
specificity of all primers for B. microti, with respect to other Babesia
spp. (data not shown).
The sensitivity test provided similar results for the two replicate
analyses. Apart from primer set B, which amplified only at the
two/three lowest dilutions, all other primer sets (A, C, D, E) showed
visible amplicons up to the fourth highest dilution (i.e., final DNA
concentration in the PCR = 1.6 pg/lL). Only primer pair D (one rep-
licate) showed positive amplification at all 5 DNA dilutions tested
(i.e., final DNA concentration in the PCR = 0.16 pg/lL). Primer pairs
D and E appeared to deliver the best performance, in terms of sen-
sitivity over a wider range of template dilutions (data not shown).
However, if sequencing is required, the longer amplicon length
offered by primer set D may be preferable.
4. Discussion
As with any novel molecular assay, the reaction conditions, re-
agent’s concentration, and thermal cycling protocol implemented
during this study, may require further validation when used in
combination with other piroplasm isolates. Despite this, the PCR
assays developed provided highly efficient amplification of a
partial fragment of the b-tubulin gene, from a human-derived B.
microti strain. Interestingly, from the phylogenetic reconstruction,
the Australian clinical isolate was more closely related to
the sequences from cluster I, identified during primer design (see
Section 2), but the molecular protocol adopted allowed positive
amplification, using any set of oligonucleotides (i.e., also those de-
signed based on the consensus sequence obtained from cluster II).
This shows that the primers may be used to amplify different ge-
netic variants of human B. microti isolates efficiently. This result
is also consistent with the fact that the primers were designed
based on an alignment of human isolates; however, screening of
additional samples, positive for a broader range of piroplasm taxa,
would be recommended. The mouse blood sample, despite having
previously tested positive for B. microti by microscopy, was older
than 5 years, and possibly unsuitable for further analysis.
The novel b-tubulin primers sets presented in this paper proved
useful for confirming the 18S rDNA-based identification of the first
case of human babesiosis in Australia. Interestingly, the patient’s
history suggested that the infection was locally acquired following
a tick bite, because, due to general ill-health, he had not worked
or travelled for many years (>40). It thus seemed unlikely that the
babesiosis was acquired from overseas. The new molecular tools
described in the present report may prove beneficial in unravelling
the intriguing questions about the origin and epidemiology of this
pathogen in Australia. For example, none of the currently recogni-Please cite this article in press as: Paparini, A., et al. Molecular confirmation of t
primer set for the beta-tubulin gene. Exp. Parasitol. (2014), http://dx.doi.org/1sed tick vectors of B. microti are known to exist in Australia, and it
is suggested that future studies should determine whether such
ticks could have become established in enzootic foci within the
country, or, alternatively, whether Australian native ticks are com-
petent vectors for this species of piroplasm. Furthermore, with
transfusion-transmitted babesiosis (TTB) currently recognised as
the most common transfusion-associated infection in the United
States (Young et al., 2012), the implications of this finding for the
Australian blood transfusion service merit investigation.
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